Literature DB >> 8629307

Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total parenteral nutrition.

A M Shapiro1, V G Bain, D L Sigalet, N M Kneteman.   

Abstract

Chylous ascites is the accumulation of chylomicronrich lymphatic fluid within the peritoneal cavity. It is a rare complication of retroperitoneal surgery, and may occur spontaneously in 0.5% of patients with cirrhosis. Its management is controversial, and despite a variety of treatment options with limited efficacy, the course is usually indolent. In this article, we report a case of rapid resolution of chylous ascites after liver transplantation following 10 days of treatment using somatostatin analog (Octreotide, 100 micrograms sc. t.i.d.) and total parenteral nutrition (TPN). A 55-year-old man underwent liver transplantation for hepatitis C cirrhosis, and developed an infected chylous fistula on the 10th day. Treatment by fasting, TPN, and somatostatin analog resulted in a rapid falloff in fistula output, with complete resolution of ascites within 2 days. This is the first report, to our knowledge, of somatostatin analog and TPN used in combination for rapid and successful closure of a chylous fistula.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8629307     DOI: 10.1097/00007890-199605150-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Spontaneous chylous peritonitis mimicking acute appendicitis: a case report and review of literature.

Authors:  Fu-Chi Fang; Sheng-Der Hsu; Chuang-Wei Chen; Teng-Wei Chen
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

2.  Peritoneovenous shunt after failure of octreotide treatment for chylous ascites in lymphangioleiomyomatosis.

Authors:  Laurent Lefrou; Louis d'Alteroche; Yahia Harchaoui; Dominique Franco; Etienne Henry Metman
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

3.  Prediction of therapeutic effectiveness according to CT findings after therapeutic lymphangiography for lymphatic leakage.

Authors:  Rika Yoshimatsu; Takuji Yamagami; Hiroshi Miura; Tomohiro Matsumoto
Journal:  Jpn J Radiol       Date:  2013-10-26       Impact factor: 2.374

Review 4.  A clinical case study: sclerosing mesenteritis presenting as chylous ascites.

Authors:  Manish Arora; Ethan Dubin
Journal:  Medscape J Med       Date:  2008-02-07

5.  Idiopathic chylous ascites in a patient with HIV infection: response to total parenteral nutrition and octreotide therapy.

Authors:  Gonçalo Nunes; Cristina Fonseca; Rita Barosa; Marta Patita; André Gomes; Júlio Botas; Hélder Coelho; Maria José Brito; Jorge Fonseca
Journal:  Clin J Gastroenterol       Date:  2018-02-09

6.  Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Answers.

Authors:  Xiaoyan Wu; Molly Vega; Sarah J Swartz; Mini Michael
Journal:  Pediatr Nephrol       Date:  2017-03-10       Impact factor: 3.714

7.  Chylous ascites secondary to pancreatitis: management of an uncommon entity using parenteral nutrition and octreotide.

Authors:  Mohammed Y Al-Ghamdi; Anil Bedi; S Bharati Reddy; Ronald T Tanton; Kevork M Peltekian
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

8.  A case of successful conservative treatment for chylous ascites after living-donor liver transplantation.

Authors:  Hiroaki Shiba; Shigeki Wakiyama; Takeshi Gocho; Yuichi Ishida; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  Int Surg       Date:  2012 Oct-Dec

9.  The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.

Authors:  Dong Xun Zhou; Hua Bang Zhou; Qing Wang; Shan Shan Zou; Hao Wang; He Ping Hu
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

10.  Acute appendicitis together with chylous ascites: is it a coincidence?

Authors:  Sami Akbulut; Davut Yilmaz; Sule Bakir; Erdal Cucuk; Mahmut Tas
Journal:  Case Rep Med       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.